MET and medulloblastoma: In medulloblastoma cells, tyrosine kinase receptor c-Met was found to induce phosphorylation of FAK and Pyk2, which in turn, mediated the malignant effects of c-Met on medulloblastoma cell proliferation, migration, and invasion [75].